Download presentation
Presentation is loading. Please wait.
Published byGerarda van de Brink Modified over 5 years ago
1
Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik J.M. van de Rest, MD, Joost R.M. Meijer, MD, Marc van Leersum, MD, Sebastiaan van Koeverden, MD, Frans L. Moll, MD, PhD, Jos C. van den Berg, MD, PhD, Jean-Paul P.M. de Vries, MD, PhD Journal of Vascular Surgery Volume 51, Issue 2, Pages (February 2010) DOI: /j.jvs Copyright © 2010 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Kaplan-Meier primary (interrupted line) and assisted primary patency (continuous line) rates of 60 mesenteric arteries treated by percutaneous transluminal angioplasty. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions
3
Fig 2 Clinical success in 51 patients treated for chronic mesenteric ischemia (CMI) by percutaneous transluminal angioplasty and stenting (PTAS). Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions
4
Fig 3 Kaplan-Meier primary (interrupted line) and assisted primary clinical success (continuous line) rates in 51 patients with chronic mesenteric ischemia treated by percutaneous transluminal angioplasty. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.